US Patent Issued to Neurocrine Biosciences on June 9 for "Substituted pyrido[2,1-aisoquinolines as VMAT2 inhibitors" (California Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,649,741, issued on June 9, was assigned to Neurocrine Biosciences Inc. (San Diego).

"Substituted pyrido[2,1-aisoquinolines as VMAT2 inhibitors" was invented by Nicole Harriott (San Diego), Nicholas Pagano (San Diego) and Byron A. Boon (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure relates generally to VMAT2 inhibitor compounds of Formula (Ia):and pharmaceutically acceptable salts thereof, as well as compositions and methods related thereto."

The patent was filed on June 9, 2023, under Application No. 18/207,807.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Par...